Choksi Laboratories Ltd.

BSE: CHOKSILA · Healthcare Service Provider · sector

₹212.95BSE close 2026-10-26

Key numbers

Market cap₹148 cr

Price₹212.95

52w high / low₹227 / ₹82

P/E68.5xSector median 22.9x

P/B5.8xSector median 2.0x

Book value₹36.7

Dividend yield–Sector median 0.55%

ROE8.8%Sector median 5.4%

ROCE11.0%Sector median 6.8%

OPM28.3%Sector median 15.9%

Debt / equity1.18xSector median 0.07x

EV/EBITDA13.4xSector median 17.2x

Interest cover2.1x

Current ratio0.82x

Sales growth 3y+10.1%Sector median +13.5%

Profit growth 3y-15.1%Sector median +26.9%

PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹0 cr vs borrowings ₹30 cr (FY26): borrowings are higher by ₹30 cr.
Operating profit covered interest 2.1x in the last 12 months.
Other income was 11% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹212.95 on 2026-10-26: -6.0% from the 52-week high, +160.2% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹224.65 · low ₹60.01

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	11	11	11	11	13	12
EBITDA	4	3	3	3	4	3
OPM %	30.7%	25.8%	26.3%	31.5%	28.5%	27.2%
Other income	0	0	0	0	0	0
Net profit	1	0	0	0	1	1
EPS (₹)	1.32	0.55	0.35	0.45	1.47	0.84
Revenue YoY					+12.5%	+7.3%
Profit YoY					+12.0%	+48.7%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	30	34	37	42	46	47
EBITDA	9	12	10	11	13	13
Net profit	0	3	1	2	2	2
EPS (₹)	0.30	4.61	1.59	2.19	2.82	3.11
Revenue growth		+14.6%	+6.6%	+13.8%	+10.1%	–
Profit growth		+1,428.6%	-65.4%	+36.9%	+28.9%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+10.1%	–	–
Net profit	-15.1%	–	–
EPS	-15.1%	–	–
Share price	–	+81.1% (2y)	+36.0%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	24	26
Borrowings	28	30
Cash & equivalents	1	0
Total assets	65	72
Fixed assets	46	47
Capital work in progress	0	0
Investments	0	0
Receivables	11	15
Inventory	1	0
Payables	5	6

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	12	9
Cash from investing	-8	-8
Cash from financing	-4	-1
Capex	8	8
Free cash flow	4	1

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	6.5%	7.7%
ROCE %	9.3%	10.8%
Debtor days	98	117
Inventory days	66	25
Payable days	639	594
Cash conversion cycle (days)	-475	-452
Working capital days	-66	-33

Peers in Healthcare Service Provider

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
LALPATHLAB	₹31,100 cr	57.2x	12.4x	23.1%	29.6%	27.9%	+11.1%	0.71%
VIJAYA	₹14,362 cr	76.6x	15.0x	21.4%	30.1%	42.2%	+21.0%	0.14%
METROPOLIS	₹10,989 cr	54.5x	7.3x	14.2%	19.7%	24.2%	+12.8%	0.19%
THYROCARE	₹7,491 cr	42.6x	12.8x	31.1%	39.7%	31.4%	+16.3%	1.99%
NEPHROPLUS	₹6,095 cr	71.6x	5.5x	6.9%	13.4%	22.7%	–	–
SURAKSHA	₹1,628 cr	45.4x	6.7x	15.7%	25.2%	31.4%	–	–
KRSNAA	₹1,617 cr	16.6x	1.6x	10.5%	11.1%	26.8%	+16.6%	0.55%
3BBLACKBIO	₹1,193 cr	21.2x	3.7x	18.7%	22.8%	34.9%	+127.8%	0.29%
HEALTHX	₹857 cr	–	3.2x	-0.5%	–	–	–	–
CHOKSILA	₹148 cr	68.5x	5.8x	8.8%	11.0%	28.3%	+10.1%	–

All 31 companies in Healthcare Service Provider →

Dividends & corporate actions

Ex-date	Action	Detail
2001-08-27	Dividend	NIL Dividend

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Healthcare Service Provider
Sub-industry	Healthcare Service Provider
Symbol	CHOKSILA
BSE code	526546
ISIN	INE493D01013
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.